Touch Briefing’s US Respiratory Disease 2007 will highlight the industry’s key opinion leaders and companies to create a unique and dynamic platform to deliver the most salient research and showcase the latest products to the respiratory community. Respiratory Illnesses are responsible for significant morbidity and mortality worldwide: chronic obstructive pulmonary disease (COPD) is the only major cause of morbidity and mortality whose incidence is rising; asthma claims over 5,000 lives in the US each year; tuberculosis remains the leading cause of death worldwide from a curable disease; and lung cancer is the most common cancer worldwide and the leading cancer killer of both men and women in the US.

Touch Briefing’s European Respiratory Disease 2007 will bring together the industry’s key opinion leaders and leading companies to create a unique and dynamic platform to deliver the most salient research and showcase the latest products to the respiratory community. Respiratory diseases and their management continue to fail to receive the attention they deserve. So, when opportunities do come along, or successes are achieved, the respiratory community must capitalise on them. One such triumph is the inclusion, finally, of allergic and respiratory disease in the 7th Framework Programme of the European Community for research, technological development and demonstration activities.